HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Misako Fukasawa Selected Research

N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide

12/2007Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
5/2006Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Misako Fukasawa Research Topics

Disease

2Schizophrenia (Dementia Praecox)
10/2020 - 10/2019
2Ischemic Stroke
12/2007 - 05/2006
2Brain Ischemia (Cerebral Ischemia)
12/2007 - 05/2006
2Stroke (Strokes)
12/2007 - 05/2006
1Vomiting
11/2020
1Sleepiness
11/2020
1Dizziness (Lightheadedness)
11/2020
1Headache (Headaches)
11/2020
1Nausea
11/2020
1Infarction (Infarctions)
05/2006
1Reperfusion Injury
05/2006

Drug/Important Bio-Agent (IBA)

2MGS 0008IBA
10/2020 - 10/2019
2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
10/2020 - 10/2019
2N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamideIBA
12/2007 - 05/2006
220-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
12/2007 - 05/2006
1ProdrugsIBA
10/2019
1EstersIBA
10/2019
1Glutamic Acid (Glutamate)FDA Link
10/2019
1triphenyltetrazoliumIBA
05/2006
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2006
1Arachidonic Acid (Vitamin F)IBA
05/2006

Therapy/Procedure

1Oral Administration
11/2020